7 results on '"Brancale J"'
Search Results
2. Protocol for enrichment, purification, and cytocentrifugation of mouse liver endothelial cells.
- Author
-
Chowdhury S, Fried KD, Iwakiri Y, Brancale J, and Vilarinho S
- Subjects
- Animals, Mice, Liver, Cell Movement, Cell Separation, Endothelial Cells, Hepatocytes
- Abstract
Liver endothelial cells (LECs) are critical in maintaining liver homeostasis. To understand the mechanistic processes occurring in these cells, high-quality isolation protocols must be in place. Here, we present a protocol for LEC enrichment, subsequent LEC purification using fluorescence-assisted cell sorting, and cytocentrifugation of sorted LECs for imaging. We describe steps for isolation of LEC-enriched population from mouse livers, immunolabeling and sorting, and cytospin and immunostaining. We then mention procedures for downstream analysis. For complete details on the use and execution of this protocol, please refer to Drzewiecki et al. (2021).
1 ., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
3. GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension.
- Author
-
Drzewiecki K, Choi J, Brancale J, Leney-Greene MA, Sari S, Dalgiç B, Ünlüsoy Aksu A, Evirgen Şahin G, Ozen A, Baris S, Karakoc-Aydiner E, Jain D, Kleiner D, Schmalz M, Radhakrishnan K, Zhang J, Hoebe K, Su HC, Pereira JP, Lenardo MJ, Lifton RP, and Vilarinho S
- Subjects
- Adolescent, Adult, Animals, Female, Hepatocytes metabolism, Humans, Liver Cirrhosis metabolism, Male, Mice, Young Adult, Endothelial Cells metabolism, GTP-Binding Proteins metabolism, Homeostasis physiology, Hypertension, Portal metabolism, Liver metabolism
- Abstract
Portal hypertension is a major contributor to decompensation and death from liver disease, a global health problem. Here, we demonstrate homozygous damaging mutations in GIMAP5, a small organellar GTPase, in four families with unexplained portal hypertension. We show that GIMAP5 is expressed in hepatic endothelial cells and that its loss in both humans and mice results in capillarization of liver sinusoidal endothelial cells (LSECs); this effect is also seen when GIMAP5 is selectively deleted in endothelial cells. Single-cell RNA-sequencing analysis in a GIMAP5-deficient mouse model reveals replacement of LSECs with capillarized endothelial cells, a reduction of macrovascular hepatic endothelial cells, and places GIMAP5 upstream of GATA4, a transcription factor required for LSEC specification. Thus, GIMAP5 is a critical regulator of liver endothelial cell homeostasis and, when absent, produces portal hypertension. These findings provide new insight into the pathogenesis of portal hypertension, a major contributor to morbidity and mortality from liver disease., Competing Interests: Disclosures: The authors declare no competing interests exist., (© 2021 Drzewiecki et al.)
- Published
- 2021
- Full Text
- View/download PDF
4. Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood.
- Author
-
Khera AV, Chaffin M, Wade KH, Zahid S, Brancale J, Xia R, Distefano M, Senol-Cosar O, Haas ME, Bick A, Aragam KG, Lander ES, Smith GD, Mason-Suares H, Fornage M, Lebo M, Timpson NJ, Kaplan LM, and Kathiresan S
- Subjects
- Adolescent, Body Mass Index, Child, Databases, Factual, Female, Genome-Wide Association Study, Humans, Infant, Newborn, Longitudinal Studies, Male, Middle Aged, Obesity genetics, Risk Factors, Severity of Illness Index, Body Weight, Multifactorial Inheritance genetics, Obesity pathology
- Abstract
Severe obesity is a rapidly growing global health threat. Although often attributed to unhealthy lifestyle choices or environmental factors, obesity is known to be heritable and highly polygenic; the majority of inherited susceptibility is related to the cumulative effect of many common DNA variants. Here we derive and validate a new polygenic predictor comprised of 2.1 million common variants to quantify this susceptibility and test this predictor in more than 300,000 individuals ranging from middle age to birth. Among middle-aged adults, we observe a 13-kg gradient in weight and a 25-fold gradient in risk of severe obesity across polygenic score deciles. In a longitudinal birth cohort, we note minimal differences in birthweight across score deciles, but a significant gradient emerged in early childhood and reached 12 kg by 18 years of age. This new approach to quantify inherited susceptibility to obesity affords new opportunities for clinical prevention and mechanistic assessment., (Copyright © 2019. Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
5. Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.
- Author
-
Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, and Chung RT
- Subjects
- Aged, Albuminuria complications, Albuminuria physiopathology, Antiviral Agents adverse effects, Drug Therapy, Combination, Female, Hepatitis C complications, Hepatitis C diagnosis, Humans, Kidney physiopathology, Male, Middle Aged, Renal Insufficiency, Chronic diagnosis, Renal Insufficiency, Chronic physiopathology, Retrospective Studies, Risk Factors, Sofosbuvir adverse effects, Sustained Virologic Response, Time Factors, Treatment Outcome, Antiviral Agents therapeutic use, Glomerular Filtration Rate drug effects, Hepatitis C drug therapy, Kidney drug effects, Renal Insufficiency, Chronic complications, Sofosbuvir therapeutic use
- Abstract
Background and Objectives: Hepatitis C virus infection is common in patients with CKD and leads to accelerated progression to ESRD. Sofosbuvir is a potent direct-acting antiviral therapy against hepatitis C virus; however, there are concerns about its safety in patients with CKD. The objective of our study was to determine the safety and efficacy of sofosbuvir in patients with CKD., Design, Setting, Participants, & Measurements: We studied a retrospective observational cohort of patients with CKD defined by eGFR<60 ml/min per 1.73 m
2 , ≥30 mg albuminuria per 1 g creatinine, or ≥200 mg proteinuria per 1 g creatinine who received sofosbuvir-based therapy in a large health care system. Regression models were constructed to predict likelihood of sustained virologic response, detect adverse events, and examine changes in eGFR from baseline to follow-up., Results: Ninety-eight patients with CKD (42% stage 1 or 2 CKD and 58% stage 3 CKD) were included. Mean age was 62 years old, 78% were men, and 65% were white. Additionally, 49% of patients had diabetes, 38% of patients had cirrhosis, and 33% of patients had prior solid organ transplant. Overall sustained virologic response was 81% and varied by regimen used and viral genotype. Average baseline eGFR was equivalent to average on-treatment eGFR, but seven patients experienced a rise in creatinine ≥1.5 times baseline while taking sofosbuvir; all but one recovered. In patients with eGFR<60 ml/min per 1.73 m2 at baseline (stage 3 CKD), regression models showed that hepatitis C cure was associated with a 9.3 (95% confidence interval, 0.44 to 18) ml/min per 1.73 m2 improvement in eGFR during the 6-month post-treatment follow-up period. Adverse events were common (81%), but serious adverse events (17%) and treatment discontinuations (8%) were uncommon., Conclusions: Sofosbuvir-based direct-acting antiviral therapy is safe and effective in a cohort of patients with CKD infected with hepatitis C., (Copyright © 2017 by the American Society of Nephrology.)- Published
- 2017
- Full Text
- View/download PDF
6. Eat Well, or Get Roommates Who Do.
- Author
-
Kaplan LM and Brancale J
- Subjects
- Gastrointestinal Microbiome, Diet, Microbiota
- Abstract
In the January issue of Cell Host & Microbe, Griffin et al. (2017) report that the intestinal microbiome adapts to dietary practices. Restricted diversity induced by a typical American diet reflects a durable loss of taxa that is replenished only when dietary manipulation is accompanied by exposure to a healthier microbiota., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
7. Shared developmental programme strongly constrains beak shape diversity in songbirds.
- Author
-
Fritz JA, Brancale J, Tokita M, Burns KJ, Hawkins MB, Abzhanov A, and Brenner MP
- Subjects
- Animals, Beak anatomy & histology, Body Weights and Measures, Cell Proliferation, Computer Simulation, Finches anatomy & histology, Selection, Genetic, Beak embryology, Finches embryology, Models, Biological, Morphogenesis physiology, Phylogeny
- Abstract
The striking diversity of bird beak shapes is an outcome of natural selection, yet the relative importance of the limitations imposed by the process of beak development on generating such variation is unclear. Untangling these factors requires mapping developmental mechanisms over a phylogeny far exceeding model systems studied thus far. We address this issue with a comparative morphometric analysis of beak shape in a diverse group of songbirds. Here we show that the dynamics of the proliferative growth zone must follow restrictive rules to explain the observed variation, with beak diversity constrained to a three parameter family of shapes, parameterized by length, depth and the degree of shear. We experimentally verify these predictions by analysing cell proliferation in the developing embryonic beaks of the zebra finch. Our findings indicate that beak shape variability in many songbirds is strongly constrained by shared properties of the developmental programme controlling the growth zone.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.